Literature DB >> 3156926

1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro.

J M Lemire, J S Adams, V Kermani-Arab, A C Bakke, R Sakai, S C Jordan.   

Abstract

The active form of vitamin D3, 1 alpha,25-dihydroxyvitamin D3 (1,25-(OH)2-D3), suppresses in vitro immunoglobulin (Ig) production by activated peripheral blood mononuclear cells (PBM) from normal human subjects by inhibiting T helper/inducer TH cell activity. Normal PBM were fractionated into B, TH and T suppressor/cytotoxic (Ts) cells by fluorescence-activated cell sorting techniques. The resultant subsets were activated with mitogens and were cultured in the presence or absence of a receptor-saturating concentration of 1,25-(OH)2-D3. The sterol reduced [3H]thymidine incorporation in TH cells by 56%, with no effect on Ts or B cells. When 1,25-(OH)2-D3-treated TH cells were co-cultured with untreated B cells and culture supernatants assayed for Ig production, 1,25-(OH)2-D3 abrogated the inducing effect of TH cells on Ig synthesis by B cells. There was no inhibitory effect of the sterol on Ts or B cell activity. In addition, 1,25-(OH)2-D3 produced a dramatic inhibition of interleukin 2 (IL 2) production by activated PBM, but did not inhibit IL 2 receptor generation by these cells. Other vitamin D metabolites tested did not produce this effect. These results suggest that the TH lymphocyte is the specific cellular target for the immunoinhibitory effects of 1,25-(OH)2-D3.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3156926

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  81 in total

Review 1.  Hormones and the immune response.

Authors:  A K Bhalla
Journal:  Ann Rheum Dis       Date:  1989-01       Impact factor: 19.103

2.  Vitamin d deficiency reduces the immune response, phagocytosis rate, and intracellular killing rate of microglial cells.

Authors:  Marija Djukic; Marie Luise Onken; Sandra Schütze; Sandra Redlich; Alexander Götz; Uwe-Karsten Hanisch; Thomas Bertsch; Sandra Ribes; Andrea Hanenberg; Simon Schneider; Cornelius Bollheimer; Cornel Sieber; Roland Nau
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

3.  Artesunate interacts with the vitamin D receptor to reverse sepsis-induced immunosuppression in a mouse model via enhancing autophagy.

Authors:  Shenglan Shang; Jiaqi Wu; Xiaoli Li; Xin Liu; Pan Li; Chunli Zheng; Yonghua Wang; Songqing Liu; Jiang Zheng; Hong Zhou
Journal:  Br J Pharmacol       Date:  2020-07-06       Impact factor: 8.739

Review 4.  Minireview: Nuclear receptors, hematopoiesis, and stem cells.

Authors:  John P Chute; Joel R Ross; Donald P McDonnell
Journal:  Mol Endocrinol       Date:  2009-11-24

Review 5.  Clinical impact of bone and calcium metabolism changes in sarcoidosis.

Authors:  G Rizzato
Journal:  Thorax       Date:  1998-05       Impact factor: 9.139

6.  Circulating pro-inflammatory cytokines are elevated and peak power output correlates with 25-hydroxyvitamin D in vitamin D insufficient adults.

Authors:  Tyler Barker; Thomas B Martins; Harry R Hill; Carl R Kjeldsberg; Brian M Dixon; Erik D Schneider; Vanessa T Henriksen; Lindell K Weaver
Journal:  Eur J Appl Physiol       Date:  2013-01-06       Impact factor: 3.078

Review 7.  Vitamin effects on the immune system: vitamins A and D take centre stage.

Authors:  J Rodrigo Mora; Makoto Iwata; Ulrich H von Andrian
Journal:  Nat Rev Immunol       Date:  2008-09       Impact factor: 53.106

8.  Identification of a vitamin D responsive element in the promoter of the rat cytochrome P450(24) gene.

Authors:  C N Hahn; D M Kerry; J L Omdahl; B K May
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

9.  A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia.

Authors:  P Larsson; L Mattsson; L Klareskog; C Johnsson
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

Review 10.  Vitamin D and systemic lupus erythematosus: state of the art.

Authors:  Laiana Schneider; Amanda Senna Pereira Dos Santos; Marcele Santos; Rafael Mendonça da Silva Chakr; Odirlei Andre Monticielo
Journal:  Clin Rheumatol       Date:  2014-02-27       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.